231 results
Early Events in Acute GVHD #Pathophys #Honc #GVHD #GraftVersusHostDisease #NEJM
GVHD #Pathophys #Honc ... GraftVersusHostDisease #NEJM
Possible Mechanisms Underlying Immune-Related Adverse Events #Pathophys #Honc #ImmuneRelatedAdverseEvents #Immunotherapy #NEJM
Events #Pathophys #Honc ... Immunotherapy #NEJM
The Pathway of Heme Synthesis, Showing Pathway Intermediates and End-Product Regulation by Heme #Pathophys #Honc #Heme
Heme #Pathophys #Honc ... Synthesis #Porphyria #NEJM
Biologic Events Leading to Chronic GVHD #Pathophys #Honc #Pharm #GVHD #GraftVersusHostDisease #Therapeutic #Pathways #NEJM
GVHD #Pathophys #Honc ... Therapeutic #Pathways #NEJM
Role of G6PD in Protection against Oxidative Damage #Pathophys #Peds #Genetics #Honc #Favism #g6pd #NEJM
Peds #Genetics #Honc ... #Favism #g6pd #NEJM
An AAV5 vector with a functional factor VIII gene tested in men with hemophilia A #EBM
hemophilia A #EBM #Honc ... VisualAbstract #NEJM
Colorectal Cancer Screening and Polyp Surveillance Intervals
Colon Cancer Screening - Modality - Interval:
 • Colonoscopy -
Colonoscopy - q10 years ... • FIT - q1 year ... stool test - q3 years ... colonography - q5 years ... Surveillance #Intervals #management
Colonoscopy Followup Intervals 
10 years: Normal colonoscopy, ≥ 20 HP < 10mm
7-10 years: 1-2 adenomas <
Intervals 10 years ... HP < 10mm 7-10 years ... SSPs < 10mm 3-5 years ... , HP ≥ 10mm 3 years ... gastroenterology #guidelines #management
Signaling Mechanism of PD-1 and PD-L1 and Inhibition of PD-1 Signaling in Microsatellite-Instability–High Cancers. MHC1 denotes
Pathophysiology #Honc ... MicrosatelliteInstability #NEJM
Managing long term side effects of chemotherapy #Management #Peds #Honc #Chemotherapy #SideEffects #Screening #Monitoring #BMJ
chemotherapy #Management ... #Peds #Honc #Chemotherapy